je.st
news
Mallinckrodt New Drug Application Granted Priority Review By FDA
2013-07-29 11:00:00| drugdiscoveryonline Home Page
Mallinckrodt recently announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the New Drug Application (NDA) for MNK-795 and granted priority review
Tags: review
application
drug
priority
Category:Biotechnology and Pharmaceuticals